Fabtech Technologies, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹92 crore and net profit of ₹15 crore for the September 2026 quarter.
Fabtech Technologies (NSE: FABTECH) closed at ₹140.37 on 20 Nov 2026, down 41.2% over the past year. Its market capitalisation is ₹624 crore and it trades at 21.0 times earnings.
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.